Trials / Completed
CompletedNCT01161888
Effect of Topical Imiquimod on Lentigo Maligna
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Jerry Marsden · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if topical imiquimod is effective in the pathological complete regression of lentigo maligna.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imiquimod | 250mg sachets to be applied at a start dose of 5 days a week. Dose will be adjusted using an algorithm according to tolerability. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2010-07-14
- Last updated
- 2012-06-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01161888. Inclusion in this directory is not an endorsement.